IBTimes -
7 Sep 2014 23:34
Dozens of public-sector agencies and private-sector companies are fast-tracking treatments and vaccines into human trials in response to Ebola virus disease outbreak in West Africa, but one leading researcher contended thousands of deaths could have been prevented had pharmaceutical companies done the required work earlier.
Share this Article